Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GABAA-receptor subtypes differing in alpha-subunit composition display unique pharmacological properties.

H Mohler1, D Benke, S Mertens

  • 1Institute of Pharmacology, University of Zurich, Switzerland.

Advances in Biochemical Psychopharmacology
|January 1, 1992
PubMed
Summary

Researchers identified distinct GABAA-receptor subtypes in rat brains using specific antibodies. These subtypes exhibit unique pharmacological profiles, suggesting potential for targeted therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paucisymptomatic opisthorchiasis in a non-endemic country: a neglected differential diagnosis?

Infection·2026
Same author

First Results on the Search for Lepton Number Violating Neutrinoless Double-β Decay with the LEGEND-200 Experiment.

Physical review letters·2026
Same author

First Constraints on General Neutrino Interactions Based on KATRIN Data.

Physical review letters·2025
Same author

Exotic Dark Matter Search with the Majorana Demonstrator.

Physical review letters·2024
Same author

Final Result of the Majorana Demonstrator's Search for Neutrinoless Double-β Decay in ^{76}Ge.

Physical review letters·2023
Same author

New Constraint on the Local Relic Neutrino Background Overdensity with the First KATRIN Data Runs.

Physical review letters·2022

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • GABAA receptors are crucial inhibitory neurotransmitter receptors in the brain.
  • Understanding GABAA-receptor subtypes is essential for developing targeted therapeutics.
  • Previous characterization of GABAA-receptor subtypes has been limited.

Purpose of the Study:

  • To characterize GABAA-receptor subtypes in the rat brain using subunit-specific antibodies.
  • To investigate the pharmacological properties of different GABAA-receptor populations.
  • To explore the potential therapeutic implications of subtype-specific ligands.

Main Methods:

  • Immunoprecipitation using anti-peptide antisera for alpha 1, alpha 3, and alpha 5 subunits.
  • Radioligand binding assays to determine receptor affinities for various ligands.

Related Experiment Videos

  • Immunohistochemistry to visualize the neuron-specific expression of receptor subtypes.

    • Main Results:

    • Alpha 1-containing GABAA receptors were highly abundant (80-90%).
    • Alpha 3 and alpha 5 subunit-containing receptors were less frequent (18-25% and 10-23%, respectively).
    • Receptor subtypes showed distinct pharmacological profiles, with varying affinities for ligands like CL 218872 and zolpidem.

    Conclusions:

    • GABAA receptor subtypes possess unique pharmacological characteristics.
    • Differential ligand affinities for GABAA receptor subtypes were observed.
    • Subtype-specific ligands may offer novel therapeutic strategies for neurological disorders.